Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy
- Conditions
- Multiple Sclerosis
- Interventions
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2022-03-23
- Lead Sponsor
- Claudio Gobbi
- Target Recruit Count
- 45
- Registration Number
- NCT04640818
- Locations
- 🇨ðŸ‡
Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Ticino, Switzerland
Multidimensional Assessment of Fatigue in Multiple Sclerosis- Observational Study - Ticino
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2014-03-07
- Last Posted Date
- 2019-03-21
- Lead Sponsor
- Claudio Gobbi
- Target Recruit Count
- 93
- Registration Number
- NCT02082002
- Locations
- 🇨ðŸ‡
Ospedale Regionale di Lugano - Civico, Lugano, Ticino, Switzerland
Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
Phase 4
Terminated
- Conditions
- Relapsing-remitting Multiple Sclerosis
- Interventions
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- Claudio Gobbi
- Target Recruit Count
- 5
- Registration Number
- NCT01701856
- Locations
- 🇨ðŸ‡
Ospedale Regionale di Lugano - Civico, Lugano, Ticino, Switzerland
Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Claudio Gobbi
- Target Recruit Count
- 27
- Registration Number
- NCT01411514
- Locations
- 🇨ðŸ‡
Osepdale Civico, Lugano, Ticino, Switzerland
Natalizumab De-escalation With Interferon Beta-1b
Phase 4
Completed
- Conditions
- Relapsing-remitting Multiple Sclerosis
- Interventions
- First Posted Date
- 2010-06-15
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Claudio Gobbi
- Target Recruit Count
- 19
- Registration Number
- NCT01144052
- Locations
- 🇨ðŸ‡
Neurocenter of Southern Switzerland, Ospedale Civico Lugano, Lugano, Ticino, Switzerland
© Copyright 2025. All Rights Reserved by MedPath